Genomic Valley Biotech Ltd Closes Trading Window for Q4 & FY 2025-2026

Genomic Valley Biotech Ltd has announced the closure of the trading window for the quarter and year ending on March 31, 2026. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The trading window will remain closed from April 1, 2026, until 48 hours after the announcement of the audited financial results for the quarter and year ended March 31, 2026. This means that employees, directors, key managerial personnel, designated persons, and their immediate relatives are prohibited from trading in the company's shares or securities during this period. The date of the board meeting for the declaration of the audited financial results will be announced in due course.